Shinya Watanabe Medical-Industrial Translational Research Center Fukushima Medical University Biography Publications Institution JoVE Articles Shinya Watanabe has not added a biography. If you are Shinya Watanabe and would like to personalize this page please email our Author Liaison for assistance. Publications A Screening System for Identifying Interacting Proteins Using Biomolecular Fluorescence Complementation and Transposon Gene Trap PloS One. 2021 | Pubmed ID: 33989302 Construction of Patient-derived Tumor Models to Evaluate Anticancer Agents and Cancer Immunotherapy Oncology Letters. May, 2021 | Pubmed ID: 33841567 Establishment of Reporter Cells That Respond to Glucocorticoids by a Transposon-mediated Promoter-trapping System European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences. Jul, 2021 | Pubmed ID: 33775826 Tumor β-catenin Expression is Associated with Immune Evasion in Non-small Cell Lung Cancer with High Tumor Mutation Burden Oncology Letters. Mar, 2021 | Pubmed ID: 33574942 Clinical Relevance of Oncogenic Driver Mutations Identified in Endometrial Carcinoma Translational Oncology. Mar, 2021 | Pubmed ID: 33450701 Clinical Implication of Oncogenic Somatic Mutations in Early-stage Cervical Cancer with Radical Hysterectomy Scientific Reports. 10, 2020 | Pubmed ID: 33127935 A Blood-based Gene-expression Scoring System for Cancer Screening in Patients With Branch-duct Intraductal Papillary Mucinous Neoplasms Anticancer Research. Nov, 2020 | Pubmed ID: 33109597 Proliferative Classification of Intracranially Injected HER2-positive Breast Cancer Cell Lines Cancers. Jul, 2020 | Pubmed ID: 32640677 Establishment and Characterization of Highly Osteolytic Luminal Breast Cancer Cell Lines by Intracaudal Arterial Injection Genes to Cells : Devoted to Molecular & Cellular Mechanisms. Feb, 2020 | Pubmed ID: 31849141 Tumor Mutation Burden and Immunological, Genomic, and Clinicopathological Factors As Biomarkers for Checkpoint Inhibitor Treatment of Patients with Non-small-cell Lung Cancer Cancer Immunology, Immunotherapy : CII. Jan, 2020 | Pubmed ID: 31807880 Prediction of Lymphovascular Space Invasion in Endometrial Cancer Using the 55-gene Signature Selected by DNA Microarray Analysis PloS One. 2019 | Pubmed ID: 31557240 An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids Cells. 05, 2019 | Pubmed ID: 31137590 A Method of Producing Genetically Manipulated Mouse Mammary Gland Breast Cancer Research : BCR. 01, 2019 | Pubmed ID: 30611295 A Highly Sensitive Trap Vector System for Isolating Reporter Cells and Identification of Responsive Genes Biology Methods & Protocols. 2018 | Pubmed ID: 32161797 Establishment and Characterization of a Novel Human Clear-cell Sarcoma of Soft-tissue Cell Line, RSAR001, Derived from Pleural Effusion of a Patient with Pleural Dissemination Anticancer Research. Sep, 2018 | Pubmed ID: 30194147 Evaluation of Anticancer Agents Using Patient-derived Tumor Organoids Characteristically Similar to Source Tissues Oncology Reports. Aug, 2018 | Pubmed ID: 29917168 Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. 08, 2018 | Pubmed ID: 29654927 Family with Sequence Similarity 83, Member B is a Predictor of Poor Prognosis and a Potential Therapeutic Target for Lung Adenocarcinoma Expressing Wild-type Epidermal Growth Factor Receptor Oncology Letters. Feb, 2018 | Pubmed ID: 29434849 TBX19 is Overexpressed in Colorectal Cancer and Associated with Lymph Node Metastasis Fukushima Journal of Medical Science. Dec, 2017 | Pubmed ID: 29199261 Evaluation System for Arrhythmogenic Potential of Drugs Using Human-induced Pluripotent Stem Cell-derived Cardiomyocytes and Gene Expression Analysis The Journal of Toxicological Sciences. 2017 | Pubmed ID: 29142174 [Exploring the Possibility of New Biomarkers of Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer (NSCLC)] Gan to Kagaku Ryoho. Cancer & Chemotherapy. Sep, 2017 | Pubmed ID: 28912405 A Novel Gene Expression Scoring System for Accurate Diagnosis of Basaloid Squamous Cell Carcinoma of the Esophagus International Journal of Oncology. Sep, 2017 | Pubmed ID: 28731134 Clinicopathological Examination of Dipeptidase 1 Expression in Colorectal Cancer Biomedical Reports. Apr, 2017 | Pubmed ID: 28413640 Autocrine and Paracrine Interactions Between Multiple Myeloma Cells and Bone Marrow Stromal Cells by Growth Arrest-specific Gene 6 Cross-talk with Interleukin-6 The Journal of Biological Chemistry. 03, 2017 | Pubmed ID: 28154173 Comparative Analysis of Gene Regulatory Networks of Highly Metastatic Breast Cancer Cells Established by Orthotopic Transplantation and Intra-circulation Injection International Journal of Oncology. Feb, 2017 | Pubmed ID: 28000849 Construction of a Novel Cell-based Assay for the Evaluation of Anti-EGFR Drug Efficacy Against EGFR Mutation Oncology Reports. Jan, 2017 | Pubmed ID: 27840973 Hepatocyte Nuclear Factor 1 Beta Induces Transformation and Epithelial-to-mesenchymal Transition FEBS Letters. 04, 2016 | Pubmed ID: 27001343 FAM83B is a Novel Biomarker for Diagnosis and Prognosis of Lung Squamous Cell Carcinoma International Journal of Oncology. Mar, 2015 | Pubmed ID: 25586059 Enhanced Expression of Retinoic Acid Receptor Alpha (RARA) Induces Epithelial-to-mesenchymal Transition and Disruption of Mammary Acinar Structures Molecular Oncology. Feb, 2015 | Pubmed ID: 25300573 Somatic 15q Break After Long-term Stable Disease in Acute Myeloid Leukemia Clinical Lymphoma, Myeloma & Leukemia. Apr, 2014 | Pubmed ID: 24361186 Cathepsin L is Highly Expressed in Gastrointestinal Stromal Tumors International Journal of Oncology. Nov, 2011 | Pubmed ID: 21769426 Na+ -Ca2+ Exchanger Expression and Its Modulation Biological & Pharmaceutical Bulletin. Mar, 2009 | Pubmed ID: 19252272 [Transcriptome Analysis of Virus-infected Cells] Uirusu. Jun, 2004 | Pubmed ID: 15449901 Ensayo in vitro de alto rendimiento utilizando organoides tumorales derivados del paciente Arisa Higa1, Nobuhiko Takahashi2,3, Gen Hiyama2, Hirosumi Tamura2, Hirotaka Hoshi2, Kenju Shimomura3, Shinya Watanabe2, Motoki Takagi2 1FUJIFILM Wako Bio Solutions Corporation, 2Medical-Industrial Translational Research Center, Fukushima Medical University, 3Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University JoVE 62668 Ricerca sul cancro
Ensayo in vitro de alto rendimiento utilizando organoides tumorales derivados del paciente Arisa Higa1, Nobuhiko Takahashi2,3, Gen Hiyama2, Hirosumi Tamura2, Hirotaka Hoshi2, Kenju Shimomura3, Shinya Watanabe2, Motoki Takagi2 1FUJIFILM Wako Bio Solutions Corporation, 2Medical-Industrial Translational Research Center, Fukushima Medical University, 3Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University JoVE 62668 Ricerca sul cancro